Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease

NCT00206687 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00206687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00206687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Terminated
Start date
January 8, 2003
Completion date
May 14, 2012
Enrollment
71 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease